ESC recommends uninterrupted vitamin K antagonists during ablation and device implantation
Milan, Italy - 23 June 2015: The European Society of Cardiology (ESC) has recommended uninterrupted anticoagulation with vitamin K antagonists during ablation and device implantation in a position paper presented today1 at EHRA EUROPACE - CARDIOSTIM 2015 and published in EP Europace.2
'Antithrombotic management in patients undergoing electrophysiology procedures' was produced by the European Heart Rhythm Association (EHRA), a registered branch of the ESC, and is endorsed by the ESC Working Group on Thrombosis, the Heart Rhythm Society (HRS) in the US and the Asia Pacific ...